Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Equity Ratio (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Equity Ratio for 8 consecutive years, with 0.9 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 21.1% to 0.9 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.9 through Dec 2025, up 21.1% year-over-year, with the annual reading at 0.9 for FY2025, 21.1% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.9 at Whitehawk Therapeutics, down from 0.94 in the prior quarter.
  • The five-year high for Equity Ratio was 0.95 in Q2 2025, with the low at 0.52 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.73, with a median of 0.86 recorded in 2022.
  • Peak annual rise in Equity Ratio hit 317.47% in 2021, while the deepest fall reached 34.18% in 2021.
  • Over 5 years, Equity Ratio stood at 0.86 in 2021, then dropped by 0.48% to 0.86 in 2022, then dropped by 7.59% to 0.79 in 2023, then dropped by 6.06% to 0.75 in 2024, then grew by 21.1% to 0.9 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.9, 0.94, and 0.95 for Q4 2025, Q3 2025, and Q2 2025 respectively.